Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head…

Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
Emilien Billon, Cécile Dalban, Stephane Oudard +17
European Urology Oncology9 Sep 2026Peer-reviewedLicence not stated6 citedGeneral biologyHAL
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Elie Rassy, Cécile Dalban, Emeline Colomba +17
Clinical Genitourinary Cancer9 Sep 2026Peer-reviewedLicence not stated19 citedGeneral biologyHAL
Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study
Maud Velev, Cécile Dalban, Christine Chevreau +24
European Journal of Cancer10 Sep 2026Peer-reviewedLicence not stated17 citedGeneral biologyHAL
Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinoma.
Nicholas J Salgia, Adil Khan, Yu Fujiwara +8
Journal for immunotherapy of cancer8 Oct 2026Peer-reviewedCC BY-NCFull textImmunology OncologyEurope PMC
Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma
Minchao Qin, Zhongwen Feng, Chao Zhang +3
PLOS One30 Oct 2026Peer-reviewedCC BYFull textGeneral biochemistry Cell biologyPLOSEurope PMCPMC

Cite

BibTeX

@article{guiard2026impact,
  title = {{Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma}},
  author = {Emeline Guiard and Florian Clatot and Caroline Even and Marion Perréard and Cyril Abdeddaim and Alison Johnson and Elodie Vauléon and Audrey Rambeau},
  journal = {European Journal of Cancer},
  year = {2026},
  month = sep,
  doi = {10.1016/j.ejca.2021.09.025},
  url = {https://normandie-univ.hal.science/hal-05750884v1},
}

RIS

TY  - JOUR
TI  - Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
AU  - Emeline Guiard
AU  - Florian Clatot
AU  - Caroline Even
AU  - Marion Perréard
AU  - Cyril Abdeddaim
AU  - Alison Johnson
AU  - Elodie Vauléon
AU  - Audrey Rambeau
PY  - 2026
DA  - 2026/09/15
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2021.09.025
UR  - https://normandie-univ.hal.science/hal-05750884v1
SN  - 0959-8049
ER  -

Related

Cite